Botanical species · safety record

Lycium chinense

The EFSA Compendium of Botanicals holds 8 constituent measurements for Lycium chinense. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Lycium chinense Mill.

8Constituent measurements
0Safety records
5Cited sources
160Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 160 licensed products naming Lycium chinense as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Extract types on licence

  • Dry
  • Extract Type TBA
  • decoction

Source material stated

  • Bark
  • Berries
  • Fruit
  • Fruit extract
  • Fruit(s)
  • Leaf
  • Lycium barbarum
  • Lycium barbarum - Root bark

What the records describe

Constituents measured

  • Acacetin 7-o-alpha-l-rhamnopyranoside1
  • Anthraquinones1
  • Calystegines1
  • Carboline alkaloids1
  • Coumarins1
  • Lignans1
  • P-coumaric acid1
  • Pterocarpans1

Plant parts

  • Roots and other underground parts6
  • Aerial part of plants1
  • Fruit unspecified1

Preparations

  • Solvent extraction8

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Acacetin 7-o-alpha-l-rhamnopyranosideRoots and other underground partsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
CalysteginesRoots and other underground partsSolvent extraction——Resolve DOI
Carboline alkaloidsFruit unspecifiedSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
LignansRoots and other underground partsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
P-coumaric acidAerial part of plantsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
PterocarpansRoots and other underground partsSolvent extraction—Nuclear Magnetic Resonance (NMR)Resolve DOI
AnthraquinonesRoots and other underground partsSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier
CoumarinsRoots and other underground partsSolvent extraction—Colorimetry, Spectroscopy (Spectrometry) and PhotometryNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Asano, N. Water soluble nortropane alkaloids in crude drugs, edible fruits and vegetables: biological activities and therapeutic applications . Mechanisms of ageing and development, 2000, vol. 116, no. 2-3, p. 155-156. DOI
  2. Wei, Xiuli., Liang, Jingyu. Chemical study on the root barks of Lycium chinese mill.. Zhongguo yaoke daxue xuebao, 2002, vol. 33, no. 4, p. 271-273.
  3. Olatunji, Opeyemi J., Chen, Hongxia., Zhou, Yifeng. Anti-Ulcerogenic Properties of Lycium chinense Mill Extracts against Ethanol-Induced Acute Gastric Lesion in Animal Models and Its Active Constituents . Molecules, 2015, vol. 20, no. 12, p. 22553-22564. DOI
  4. Han, B.H., Park, J.H., Park, M.H., Han, Y.N. Studies on the alkaloidal components of the fruits of Lycium chinense. Archives of pharmacal research, 1985, vol. 8, no. 4, p. 249-252. DOI
  5. Yang, Ya-Nan., An, Ya-Wen., Zhan, Zhi-Lai., Xie, Jing., Jiang, Jian-Shuang., Feng, Zi-Ming., Ye, Fei., Zhang, Pei-Cheng. Nine new compounds from the root bark of Lycium chinense and their alpha-glucosidase inhibitory activity . Rsc advances, 2017, vol. 7, no. 2, p. 805-812. DOI

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue